Microsalt plc
MicroSalt Plc is an early-stage AIM-listed (London) UK technology company that develops and sells low-sodium salt and snack-food ingredient solutions. Its patented process produces micron-sized salt crystals that deliver full flavour with approximately 50% less sodium than traditional salt, sold in bulk/B2B form to multinational food manufacturers and QSR/FSR foodservice channels, primarily in North America. The Group operates through its 92%-owned US subsidiary MicroSalt Inc. and is controlled by Tekcapital plc.
FY2025 in sixty seconds
year to 31 Dec 2025 · approved 27 May 2026 · 59 pages · Companies House
MicroSalt Plc makes a low-sodium salt with tiny crystals and sells it to food manufacturers and restaurant chains, mainly in North America. In the year to 31 December 2025, revenue rose to $2.1m from $750k (+175.9%), and the loss after tax narrowed to $3.5m from $6.1m.
The report credits large, repeat bulk orders from food manufacturers for the growth, with three customers making up 76% of revenue. New products launched in 2025 also helped. Its products now sell for more than they cost to make: gross profit was $87k, against a loss of $438k the year before.
The company ended the year with $1.9m in cash, up from $261k, helped by $5.7m raised from shareholders. It owes $2.9m in loans from its controlling shareholder, Tekcapital, due in 2027. No dividend was paid. Management updated its 2026 sales guidance to US$4.5 million, citing production timing rather than demand, and kept its 2027 estimate of US$15 million. The directors and auditor flag a material uncertainty over whether the company can keep going, because its cash depends on the timing of customer sales.
B2B bulk ingredient sales to multinational food manufacturers (Customers 1-3)
3 customers made up 76% of FY2025 revenue (FY24: 65%); Customer 1 (~80% of Mexican snack food market) used MicroSalt across three established snack products
page 6Scale efficiencies and shift toward higher-margin bulk ingredient sales
As the Company continues shifting toward higher-margin bulk ingredient sales, expect additional margin improvements through scale efficiencies
page 8Updating FY2026 sales guidance to US$4.5 million, reflecting anticipated production timing associated with the 2027 launch schedule rather than a change in demand outlook; reaffirms 2027 sales estimate of US$15 million
page 3The Directors do not recommend payment of a dividend; no dividends paid or proposed in FY2025 or FY2024
page 124 years on one page · FY2022–FY2025
| Line | FY2022locked | FY202312/23 | FY202412/24 | FY202512/25 |
|---|---|---|---|---|
| Revenue | ||||
| Operating profit | ||||
| Profit for the year | ||||
| Basic EPS | ||||
| Free cash flow | ||||
| Net debt (negative = net cash) | ||||
| Shares in issue | ||||
| Operating margin | ||||
| Return on capital employed |
USD millions, negatives in brackets. Per-share lines in cents. Share counts in millions. Margins and returns as percentages, calculated from the filed figures. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated.
Nothing restated
Every figure is read again from the following year’s report: 68 confirmed, 2 differ.
No figure has been restated: every figure a later report printed again, it printed the same.